Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bunazosin tablets vs risperidone in Chinese patients with schizophrenia
CTR20160592Phase 2Completed
- Sponsor
- Nanjing Huawei Pharmaceutical Technology Development
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bunazosin in schizophrenia, sponsored by Nanjing Huawei Pharmaceutical Technology Development. Started Sep 2016; status: completed.
02
Drugs
bunazosin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on CTR20160592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160592.